Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities

Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities
复制标题

DOI:
10.1046/j.1360-0443.2002.t01-1-00211.x
复制
发表时间:
2002-10-01
期刊:
影响因子:
6
通讯作者:
Singer, M
Singer, M
中科院分区:
医学1区
文献类型:
--
作者:
Heimer, R;Clair, S;Singer, M

文献摘要

被引文献

相似文献

注射吸毒是艾滋病毒和肝炎感染的主要危险因素。尽管预防新感染的计划集中在艾滋病毒上,但他们通常忽视了B和C型肝炎。本研究旨在探讨HIV和肝炎知识、危险药物制备和注射实践以及注射器交换计划(SEPs)参与情况之间的相互关系。设计调查注射吸毒者(IDUs),收集有关社会人口统计学、病史、药物使用和注射实践以及HIV和肝炎相关知识的数据。CA.Participants研究人群是一个方便的样本493 IDUs招募使用街头推广和雪球sampling strategies.Measurements艾滋病毒和肝炎的知识,注射相关的病毒传播的风险,两者之间的关联,并与SEP use.Findings艾滋病毒知识显着高于肝炎知识SEP客户和非客户的一致好评。肝炎知识的提高与药物滥用治疗史、肝炎感染、B型肝炎疫苗接种和注射实践有关,这些实践减少了与受污染的血液或水的接触,但与使用SEP无关。SEP客户始终不太可能从事危险行为,安全止血postinjection.Conclusion增加肝炎意识的注射吸毒者之间是必要的,以减少肝炎传播的显着例外。虽然SEPs继续有效地传播艾滋病毒预防信息-证明了他们的客户之间的风险行为降低-他们必须做更多的工作,以防止肝炎传播。
Aims Injection drug use is a major risk factor for HIV and hepatitis infections. Whereas programs to prevent new infections have focused on HIV, they have generally neglected hepatitis B and C. This study was designed to examine the interrelationships among HIV and hepatitis knowledge, risky drug preparation and injection practices, and participation in syringe exchange programs (SEPs).Design Surveys of injection drug users (IDUs) collected data on sociodemographics, medical history, drug use and injection practices, and HIV- and hepatitis-related knowledge.Setting Inner-city US neighborhoods in Chicago, IL, Hartford, CT and Oakland, CA.Participants The study population was a convenience sample of 493 IDUs recruited using street outreach and snowball sampling strategies.Measurements HIV and hepatitis knowledge, injection-related risks for virus transmission, associations between the two, and with SEP use.Findings HIV knowledge was significantly higher than hepatitis knowledge among SEP customers and non-customers alike. Elevated hepatitis knowledge was associated with a history of substance abuse treatment, hepatitis infection, hepatitis B vaccination and injection practices that reduced contact with contaminated blood or water but not with SEP use. SEP customers were consistently less likely to engage in risk behaviors, with the notable exception of safely staunching blood postinjection.Conclusion Increased hepatitis awareness among IDUs is necessary for reducing hepatitis transmissions. Although SEPs continue to effectively disseminate HIV prevention messages-as evidenced by lowered risk behaviors among their customers-they must do more to prevent hepatitis transmissions.